Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection

13 May 2021

Abstract excerpt

COVID-19 has currently become the biggest challenge in the world. There is still no specific medicine for COVID-19, which leaves a critical gap for the identification of new drug candidates for the disease. Recent studies have reported that the small-molecule enoxacin exerts an antiviral activity by enhancing the RNAi pathway. The aim of this study is to analyze if enoxacin can exert anti-SARS-CoV-2 effects. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Peptides and Activities
Share to RNA Interference and Gene Delivery
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33986351
DOI: 10.1038/s41598-021-89605-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infectionPMID 33986351Read ↗

Prospects for RNAi Therapy of COVID-19Semantic proximity Read ↗

The Potential Therapeutic Effect of RNA Interference and Natural Products on COVID-19: A Review of the Coronaviruses InfectionSemantic proximity Read ↗

In Silico and In Vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read ↗

Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with AntiviralsSemantic proximity Read ↗

MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19Semantic proximity Read ↗

Small molecules in the treatment of COVID-19Semantic proximity Read ↗

Role of microRNAs in COVID-19 with implications for therapeuticsSemantic proximity Read ↗

In Silico and In Vitro Development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2Semantic proximity Read ↗

Genomics functional analysis and drug screening of SARS-CoV-2Semantic proximity Read ↗

The potential of miRNA-based therapeutics in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A reviewSemantic proximity Read ↗

An in silico analysis of effective siRNAs against COVID‐19 by targeting the leader sequence of SARS‐CoV‐2Semantic proximity Read ↗

Potential Use of Noncoding RNAs and Innovative Therapeutic Strategies to Target the 5’UTR of SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.